Scotts Miracle-Gro (NYSE:SMG) Updates FY 2026 Earnings Guidance

Scotts Miracle-Gro (NYSE:SMG) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 4.150-4.35 for the period, compared to the consensus EPS estimate of 4.280. The company issued revenue guidance of -.

Scotts Miracle-Gro Stock Performance

SMG stock opened at $65.70 on Friday. Scotts Miracle-Gro has a 1 year low of $45.61 and a 1 year high of $71.78. The stock’s 50 day moving average price is $58.90 and its 200 day moving average price is $59.42. The firm has a market cap of $3.81 billion, a P/E ratio of 44.69 and a beta of 1.95.

Scotts Miracle-Gro (NYSE:SMG) last posted its quarterly earnings results on Wednesday, January 28th. The basic materials company reported ($0.77) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.04) by $0.27. Scotts Miracle-Gro had a negative return on equity of 68.59% and a net margin of 2.68%.The firm had revenue of $354.40 million during the quarter, compared to the consensus estimate of $353.25 million. During the same quarter in the previous year, the business earned ($0.89) earnings per share. The firm’s quarterly revenue was down 3.3% compared to the same quarter last year. Scotts Miracle-Gro has set its FY 2026 guidance at 4.150-4.35 EPS. On average, research analysts predict that Scotts Miracle-Gro will post 3.42 earnings per share for the current year.

Scotts Miracle-Gro Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 6th. Investors of record on Friday, February 20th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 4.0%. The ex-dividend date is Friday, February 20th. Scotts Miracle-Gro’s dividend payout ratio (DPR) is presently 109.09%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Wells Fargo & Company boosted their price objective on Scotts Miracle-Gro from $67.00 to $70.00 and gave the stock an “overweight” rating in a report on Thursday. UBS Group set a $67.00 price target on shares of Scotts Miracle-Gro in a research note on Thursday. Weiss Ratings reiterated a “hold (c-)” rating on shares of Scotts Miracle-Gro in a research report on Wednesday, January 21st. Wall Street Zen lowered Scotts Miracle-Gro from a “buy” rating to a “hold” rating in a research report on Saturday, October 25th. Finally, Stifel Nicolaus set a $70.00 target price on shares of Scotts Miracle-Gro and gave the company a “buy” rating in a research report on Thursday, November 6th. Five analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Scotts Miracle-Gro presently has an average rating of “Moderate Buy” and an average target price of $71.00.

Key Scotts Miracle-Gro News

Here are the key news stories impacting Scotts Miracle-Gro this week:

• Positive Sentiment: Company set long‑term growth targets and announced a $500M share‑repurchase program while moving to divest Hawthorne, signaling a clearer, consumer‑focused strategy that reduces cannabis exposure and returns capital to shareholders. MSN: Growth targets & buyback
• Positive Sentiment: Wells Fargo raised its price target to $70 and moved to an “overweight” rating, providing a credible analyst boost to the shares. Price target raise
• Positive Sentiment: Q1 results beat consensus on both revenue and adjusted EPS (loss narrowed); management reaffirmed fiscal 2026 outlook, which supports near‑term investor confidence. Zacks: Q1 beat
• Neutral Sentiment: UBS nudged its price target to $66 (from $61) but kept a Neutral rating, reflecting continued caution in the consumer staples backdrop despite modestly improved estimates. InsiderMonkey: UBS update
• Neutral Sentiment: Board and shareholders approved expanded equity incentive plans at the annual meeting; standard for retention but potentially modestly dilutive over time. TipRanks: Equity incentives
• Negative Sentiment: On a cautionary note, GAAP results showed a wider Q1 loss and revenue was down year‑over‑year; the FY 2026 EPS guidance range (4.15–4.35) sits slightly below consensus (~4.28), leaving some risk if consumer demand softens. MSN: Q1 loss & guidance

Institutional Investors Weigh In On Scotts Miracle-Gro

A number of hedge funds have recently added to or reduced their stakes in SMG. Caitong International Asset Management Co. Ltd bought a new stake in Scotts Miracle-Gro during the 3rd quarter worth approximately $32,000. CIBC Private Wealth Group LLC raised its stake in shares of Scotts Miracle-Gro by 104.2% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 1,448 shares of the basic materials company’s stock valued at $82,000 after purchasing an additional 739 shares during the period. Advisory Services Network LLC bought a new position in Scotts Miracle-Gro in the 3rd quarter worth about $121,000. State of Wyoming bought a new stake in shares of Scotts Miracle-Gro during the 2nd quarter valued at about $216,000. Finally, EP Wealth Advisors LLC bought a new stake in shares of Scotts Miracle-Gro during the 2nd quarter worth $222,000. Institutional investors and hedge funds own 74.07% of the company’s stock.

Scotts Miracle-Gro Company Profile

Scotts Miracle-Gro Company is a leading developer, manufacturer and distributor of consumer lawn and garden products. The firm serves both retail and professional customers through an array of branded offerings that include lawn fertilizers, grass seed, pest and disease control solutions, plant foods and specialty products for indoor and outdoor gardening. Its portfolio spans well-known names such as Scotts®, Miracle-Gro®, Ortho® and various hydroponic and specialty garden brands.

Headquartered in Marysville, Ohio, the company traces its roots to O.M.